Although our findings suggest that both nuclear expression of OCT4 and nucleocytoplasmic expressions of NANOG have implications in RCC prognosis, conducting further studies with larger sample size and prolonged follow-up time is highly recommended. This evidence concerns the gene NANOG and renal cell carcinoma.